Literature DB >> 20470827

Positive predictive value of anti-HCMV IgM as an index of primary infection.

Massimo De Paschale1, Carlo Agrappi, Maria Teresa Manco, Pierangelo Clerici.   

Abstract

A search for specific IgM antibodies was used for the detection of primary human cytomegalovirus (HCMV) infections, but the significance of the results is limited by the possible persistence of specific IgM over time, the fact that they are also produced during episodes of reactivation or reinfection, and possible cross-reactions with other viruses. Anti-HCMV antibody screening was carried out to assess the positive predictive value of detecting specific IgM antibodies using IgG and IgM enzyme-linked immunosorbent assays (ELISAs) in 6990 patients examined during the period 2005-2007. In comparison with IgG avidity, the positive predictive value of screening by IgM ELISA alone was 49.3%, which increased to 73% when the presence of IgM was confirmed by an enzyme-linked fluorescent assay (ELFA). The predictive values of highly or weakly positive IgM ELISA alone were respectively 68.8% and 16.4%, but increased to 83.1% and 39.1% if IgM was confirmed by ELFA. The positive predictive value of the IgM/IgG ratio ranged from 26.7% for a low ratio and the detection of IgM by ELISA alone, to 90.7% for a high ratio and ELFA-confirmed IgM detection. These findings indicate that a specimen in which highly positive IgM ELISA values are confirmed by ELFA, or which shows a high IgM/IgG ratio, is a good indicator of infection occurring within the previous three months. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20470827     DOI: 10.1016/j.jviromet.2010.05.001

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Potential impact of different cytomegalovirus (CMV) IgM assays on an algorithm requiring IgM reactivity as a criterion for measuring CMV IgG avidity.

Authors:  Harry E Prince; Mary Lapé-Nixon; Andrew Brenner; Nancy Pitstick; Marc Roger Couturier
Journal:  Clin Vaccine Immunol       Date:  2014-03-26

Review 2.  Breast cancer and cytomegalovirus.

Authors:  A K Richardson; L C Walker; B Cox; H Rollag; B A Robinson; H Morrin; J F Pearson; J D Potter; M Paterson; H-M Surcel; E Pukkala; M J Currie
Journal:  Clin Transl Oncol       Date:  2019-06-29       Impact factor: 3.405

Review 3.  Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.

Authors:  Harry E Prince; Mary Lapé-Nixon
Journal:  Clin Vaccine Immunol       Date:  2014-08-27

Review 4.  Performance of Zika Assays in the Context of Toxoplasma gondii, Parvovirus B19, Rubella Virus, and Cytomegalovirus (TORCH) Diagnostic Assays.

Authors:  Bettie Voordouw; Barry Rockx; Thomas Jaenisch; Pieter Fraaij; Philippe Mayaud; Ann Vossen; Marion Koopmans
Journal:  Clin Microbiol Rev       Date:  2019-12-11       Impact factor: 26.132

Review 5.  Screening for cytomegalovirus during pregnancy.

Authors:  Stuart P Adler
Journal:  Infect Dis Obstet Gynecol       Date:  2011-08-09

6.  Joint association of carrying HLA-B*13:01 gene and human herpesvirus-6 with occupational trichloroethylene hypersensitivity syndrome.

Authors:  Dianpeng Wang; Dafeng Lin; Peimao Li; Huimin Liu; Yanhua Yang; Zhimin Zhang; Qiuyue Kong; Yanfang Zhang; Xianqing Huang
Journal:  Int Arch Occup Environ Health       Date:  2019-02-13       Impact factor: 2.851

Review 7.  Diagnostic workup for diffuse parenchymal lung disease: schematic flowchart, literature review, and pitfalls.

Authors:  Barbara Deconinck; Johny Verschakelen; Johan Coolen; Eric Verbeken; Geert Verleden; Wim Wuyts
Journal:  Lung       Date:  2012-11-13       Impact factor: 3.777

8.  The polymorphism at residue 156 determines the HLA-B*35 restricted peptide repertoire during HCMV infection.

Authors:  Wiebke C Abels; Trishna Manandhar; Heike Kunze-Schumacher; Rainer Blasczyk; Christina Bade-Döding
Journal:  Immunogenetics       Date:  2018-08-21       Impact factor: 2.846

9.  Epidemiological survey of human cytomegalovirus antibody levels in children from Southeastern China.

Authors:  Qi Zhang; Yan Gao; Ying Peng; Miao Fu; Yan-Qing Liu; Qiu-Ju Zhou; Jian Yu; Xiao-Qun Zheng
Journal:  Virol J       Date:  2014-07-04       Impact factor: 4.099

10.  Severe neonatal cytomegalovirus infection: about a case.

Authors:  Brahim El Hasbaoui; Amal Bousselamti; Mohammed Amine Redouani; Amina Barkat
Journal:  Pan Afr Med J       Date:  2017-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.